av/pharming-group--big.svg

AMS:PHARM

Pharming Group N.V.

  • Stock

Last Close

0.69

25/09 14:25

Volume Today

3.36M

Avg: 10.50M

PE Ratio

−38.02

PFCF: −32.60

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
4.68M
-
11.44M
144.52%
17.02M
48.81%
18.31M
7.55%
20.43M
11.61%
20.90M
2.30%
18.01M
13.85%
18.70M
3.84%
24.24M
29.62%
34.80M
43.60%
46.85M
34.62%
average payables
3.52M
-
4.57M
29.64%
2.34M
48.69%
3.53M
50.44%
8.63M
144.61%
9.46M
9.58%
6.80M
28.13%
9.74M
43.36%
27.96M
186.98%
48.45M
73.27%
59.23M
22.26%
average receivables
693.75K
-
1.28M
84.78%
2.49M
94.51%
7.62M
205.74%
12.10M
58.66%
15.26M
26.16%
22.29M
46.07%
29.11M
30.58%
30.94M
6.31%
28.79M
6.98%
34.70M
20.55%
book value per share
0.03
-
0.09
184.20%
0.06
30.39%
0.07
9.05%
0.05
35.18%
0.12
158.33%
0.19
60.78%
0.29
54.23%
0.30
3.96%
0.32
5.09%
capex per share
-0.00
-
-0.00
249.89%
-0.00
408.13%
-0.00
59.57%
-0.01
278.07%
-0.01
50.96%
-0.04
471.59%
-0.03
36.28%
-0.02
3.97%
-0.00
87.74%
capex to depreciation
-2.00
-
-1.77
11.61%
-0.57
67.54%
-4.39
663.53%
-1.84
58.06%
-0.85
53.68%
-0.15
82.41%
-0.09
38.68%
capex to operating cash flow
0.00
-
0.03
1,052.03%
0.05
87.45%
0.15
176.76%
-0.16
204.53%
-0.09
40.99%
-0.34
265.59%
-0.18
46.96%
-0.44
144.01%
-0.09
80.45%
0.07
180.24%
capex to revenue
-0.00
-
-0.01
136.90%
-0.08
1,040.92%
-0.10
15.01%
-0.07
29.28%
-0.03
58.65%
-0.13
381.81%
-0.07
46.34%
-0.08
16.56%
-0.01
88.56%
-0.01
37.93%
cash per share
0.11
-
0.10
3.88%
0.08
19.34%
0.08
4.62%
0.14
74.17%
0.15
7.69%
0.12
22.40%
0.32
174.81%
0.30
7.53%
0.32
7.03%
days of inventory on hand
1.56K
-
1.43K
8.68%
1.23K
13.56%
1.40K
13.31%
537.72
61.55%
284.94
47.01%
247.27
13.22%
305.26
23.45%
493.38
61.63%
879.68
78.30%
804.22
8.58%
days payables outstanding
1.32K
-
313.45
76.29%
77.26
75.35%
440.53
470.20%
276.57
37.22%
109.30
60.48%
91.46
16.32%
194.34
112.49%
767.29
294.81%
1.13K
47.53%
1.00K
11.51%
days sales outstanding
32.80
-
24.29
25.94%
100.89
315.33%
261.82
159.51%
41.47
84.16%
43.22
4.21%
50.66
17.21%
51.04
0.75%
57.58
12.83%
49.03
14.86%
67.21
37.09%
debt to assets
0.06
-
0.03
54.54%
0.28
863.30%
0.53
93.25%
0.49
7.97%
0.34
30.52%
0.23
33.09%
0.39
70.19%
0.41
5.19%
0.39
3.84%
0.31
21.37%
debt to equity
0.39
-
0.05
86.46%
0.67
1,148.32%
2.45
268.68%
4.32
76.23%
1.18
72.69%
0.50
58.02%
0.88
78.08%
0.84
5.03%
0.81
2.85%
0.65
20.45%
dividend yield
earnings yield
-0.68
-
-0.05
93.28%
-0.10
107.54%
-0.20
115.00%
-0.16
23.27%
0.06
139.63%
0.04
33.62%
0.05
21.56%
0.03
38.86%
0.02
40.66%
enterprise value
9.75M
-
113.30M
1,061.57%
97.14M
14.26%
127.48M
31.23%
638.17M
400.61%
451.07M
29.32%
965.62M
114.07%
766.06M
20.67%
467.42M
38.98%
710.08M
51.91%
99.40M
86.00%
enterprise value over ebitda
-0.62
-
30.48
5,047.84%
-6.59
121.61%
-9.14
38.77%
-16.03
75.36%
8.85
155.20%
12.80
44.72%
8.32
35.05%
10.04
20.71%
21.78
116.93%
-8.39
138.52%
ev to operating cash flow
-0.85
-
-17.65
1,972.15%
-5.41
69.35%
-12.12
123.95%
13.92
214.89%
9.77
29.84%
12.95
32.62%
8.42
34.99%
12.94
53.66%
31.01
139.68%
-5.09
116.40%
ev to sales
1.03
-
4.40
326.11%
8.21
86.58%
7.64
6.94%
5.94
22.27%
2.92
50.84%
5.10
74.77%
3.35
34.23%
2.46
26.60%
3.45
40.26%
0.44
87.31%
free cash flow per share
-0.05
-
-0.02
68.82%
-0.05
177.80%
-0.03
37.06%
0.08
364.45%
0.07
10.49%
0.08
13.59%
0.12
49.34%
0.03
73.17%
0.03
2.66%
free cash flow yield
-0.38
-
-0.04
88.54%
-0.17
283.21%
-0.13
18.82%
0.06
147.00%
0.09
44.28%
0.05
45.11%
0.09
84.03%
0.04
55.97%
0.03
31.25%
graham net net
-0.04
-
0.05
216.39%
0.02
55.73%
-0.13
678.66%
-0.17
36.44%
-0.10
43.30%
-0.06
39.64%
0.01
112.37%
0.04
404.64%
0.04
17.46%
graham number
0.27
-
0.19
27.94%
0.20
2.34%
0.26
34.82%
0.44
67.29%
0.35
20.31%
0.52
48.61%
0.64
23.35%
0.40
37.77%
0.39
3.49%
income quality
0.76
-
1.11
46.39%
1.80
61.99%
0.87
51.92%
1.74
101.17%
1.06
39.06%
1.09
2.82%
1.92
75.40%
1.64
14.45%
1.53
6.83%
2.09
36.69%
intangibles to total assets
0.01
-
0.01
8.15%
0.01
9.99%
0.45
3,461.50%
0.34
23.78%
0.24
28.29%
0.31
26.97%
0.22
27.54%
0.21
6.15%
0.18
16.39%
0.15
12.46%
interest coverage
-2.10
-
16.44
881.33%
-103.50
729.56%
-3.22
96.89%
1.24
138.40%
2.65
114.90%
5.11
92.52%
12.83
151.02%
4.71
63.32%
3.40
27.69%
-3.17
193.11%
interest debt per share
0.03
-
0.01
83.98%
0.04
688.96%
0.18
320.15%
0.24
32.12%
0.16
30.71%
0.11
30.62%
0.27
132.18%
0.26
1.54%
0.27
1.66%
inventory turnover
0.23
-
0.26
9.51%
0.30
15.68%
0.26
11.75%
0.68
160.05%
1.28
88.71%
1.48
15.23%
1.20
19.00%
0.74
38.13%
0.41
43.91%
0.45
9.38%
invested capital
0.39
-
0.05
86.46%
0.67
1,148.32%
2.45
268.68%
4.32
76.23%
1.18
72.69%
0.50
58.02%
0.88
78.08%
0.84
5.03%
0.81
2.85%
0.65
20.45%
market cap
30.46M
-
152.93M
402.08%
114.39M
25.20%
90.14M
21.20%
611.00M
577.86%
459.51M
24.79%
981.75M
113.65%
809.33M
17.56%
497.56M
38.52%
750.73M
50.88%
net current asset value
-2.48M
-
28.29M
1,238.97%
18.86M
33.33%
-39.05M
306.99%
-70.95M
81.70%
-42.76M
39.73%
-19.07M
55.39%
28.24M
248.06%
45.00M
59.33%
56.34M
25.21%
67.08M
19.07%
net debt to ebitda
1.31
-
-10.66
915.35%
1.17
110.97%
-2.68
328.89%
-0.68
74.52%
-0.17
75.72%
-0.21
29.14%
-0.47
119.62%
-0.65
37.77%
-1.25
92.63%
-8.39
572.88%
net income per share
-0.10
-
-0.02
81.73%
-0.03
50.45%
-0.04
66.68%
-0.19
331.74%
0.05
124.59%
0.06
37.36%
0.06
1.35%
0.02
62.75%
0.02
11.38%
operating cash flow per share
-0.05
-
-0.02
69.63%
-0.04
171.08%
-0.03
42.35%
0.09
461.69%
0.08
16.89%
0.12
56.35%
0.14
20.12%
0.06
60.65%
0.04
37.27%
payables turnover
0.28
-
1.16
321.70%
4.72
305.72%
0.83
82.46%
1.32
59.28%
3.34
153.03%
3.99
19.51%
1.88
52.94%
0.48
74.67%
0.32
32.22%
0.36
13.01%
receivables turnover
11.13
-
15.03
35.02%
3.62
75.92%
1.39
61.47%
8.80
531.31%
8.45
4.04%
7.21
14.68%
7.15
0.74%
6.34
11.37%
7.44
17.45%
5.43
27.06%
research and ddevelopement to revenue
1.50
-
0.55
63.18%
1.31
137.88%
0.97
25.97%
0.21
78.53%
0.21
2.67%
0.17
21.47%
0.18
8.17%
0.35
94.91%
0.26
27.80%
0.28
9.96%
return on tangible assets
-0.49
-
-0.10
78.39%
-0.17
66.56%
-0.25
43.08%
-0.73
191.75%
0.15
121.12%
0.23
49.18%
0.13
45.61%
0.05
61.01%
0.04
20.04%
-0.03
167.96%
revenue per share
0.04
-
0.07
47.69%
0.03
55.46%
0.04
38.74%
0.21
434.62%
0.25
18.60%
0.30
18.63%
0.36
18.74%
0.30
17.62%
0.32
7.19%
roe
-3.01
-
-0.19
93.57%
-0.42
116.14%
-0.64
52.85%
-4.25
566.09%
0.40
109.52%
0.35
14.57%
0.22
36.04%
0.08
64.17%
0.07
15.68%
-0.05
170.59%
roic
-1.17
-
0.09
107.42%
-0.34
490.00%
-0.15
57.22%
0.19
233.94%
8.20
4,116.07%
0.29
96.46%
0.20
31.95%
0.05
73.93%
0.04
20.07%
-0.06
253.27%
sales general and administrative to revenue
0.37
-
0.16
57.36%
0.35
120.38%
0.29
15.42%
0.07
77.21%
0.09
35.67%
0.11
23.73%
0.06
43.58%
0.19
194.50%
0.22
20.37%
shareholders equity per share
0.03
-
0.09
184.20%
0.06
30.39%
0.07
9.05%
0.05
35.18%
0.12
158.33%
0.19
60.78%
0.29
54.23%
0.30
3.96%
0.32
5.09%
stock based compensation to revenue
0.03
-
0.05
47.81%
0.03
31.74%
tangible asset value
6.36M
-
35.34M
455.83%
25.27M
28.50%
-30.72M
221.57%
-45.38M
47.72%
10.66M
123.48%
37.94M
256.03%
89.49M
135.88%
108.97M
21.76%
129.52M
18.86%
133.91M
3.39%
tangible book value per share
0.03
-
0.09
201.15%
0.06
30.70%
-0.07
219.61%
-0.09
22.62%
0.02
119.37%
0.06
244.83%
0.14
132.19%
0.17
20.67%
0.20
17.63%
working capital
16.12M
-
41.67M
158.51%
41.13M
1.31%
11.37M
72.35%
35.66M
213.59%
37.57M
5.35%
5.17M
86.23%
186.66M
3,509.21%
202.46M
8.47%
217.80M
7.58%
217.45M
0.16%

All numbers in (except ratios and percentages)